scispace - formally typeset
L

Lilach O. Lerman

Researcher at Mayo Clinic

Publications -  695
Citations -  35123

Lilach O. Lerman is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Kidney & Renal function. The author has an hindex of 78, co-authored 633 publications receiving 29750 citations. Previous affiliations of Lilach O. Lerman include University of California, San Diego & Minnesota State University, Mankato.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Endothelial Dysfunction A Marker of Atherosclerotic Risk

Piero O. Bonetti, +2 more
- 01 Feb 2003 - 
TL;DR: Given its reversibility and granted the availability of a diagnostic tool to identify patients at risk and to control the efficacy of therapy in clinical practice, endothelial dysfunction may be an attractive primary target in the effort to optimize individualized therapeutic strategies to reduce cardiovascular morbidity and mortality.
Journal ArticleDOI

Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease.

La Tonya J. Hickson, +32 more
- 01 Sep 2019 - 
TL;DR: “Hit-and-run” treatment with senolytics, which in the case of D’+ Q have elimination half-lives <11 h, significantly decreases senescent cell burden in humans.
Journal ArticleDOI

Prognostic Value of Flow‐Mediated Vasodilation in Brachial Artery and Fingertip Artery for Cardiovascular Events: A Systematic Review and Meta‐Analysis

Yasushi Matsuzawa, +4 more
- 09 Nov 2015 - 
TL;DR: Noninvasive peripheral endothelial function tests, FMD and RH‐PAT, significantly predicted cardiovascular events, with similar prognostic magnitude.
Journal ArticleDOI

Ubiquitin and Ubiquitin-Like Proteins in Protein Regulation

Joerg Herrmann, +2 more
- 11 May 2007 - 
TL;DR: This review provides an overview of this class of molecules and its implication for function, subcellular location, and half-life of proteins.